Cercle has entered into a strategic partnership with MedITEX, the leading fertility EMR provider in Europe, to distribute its AI platform across MedITEX’s global network of fertility clinics. The partnership will enable clinics using MedITEX to access Cercle’s analytics and predictive tools seamlessly within their existing workflows.
Founded over 25 years ago, MedITEX has grown into one of the most trusted and widely adopted EMRs in fertility care. Today, MedITEX supports more than 600 partner clinics across 50+ countries, offering a robust suite of digital tools for clinical documentation, lab management, and patient engagement.
With a reputation for innovation and deep specialization in reproductive medicine, MedITEX has consistently expanded its global footprint while maintaining a focus on data integrity and usability. This partnership with Cercle marks a major step forward in providing clinics with advanced capabilities for improving IVF outcomes, enhancing patient conversion, and reducing cost inefficiencies.
Michael Schindler, CEO of MedITEX, emphasized the alignment of missions between the two companies. “Our goal has always been to empower fertility professionals with technology that simplifies complexity and improves care. Cercle brings the artificial intelligence layer our customers have been asking for—turning their data into predictive, actionable insights that make a real difference in both patient outcomes and operational success.”
Ashley Finch, COO of Cercle, shared her excitement about the collaboration. “MedITEX is a cornerstone of fertility care globally. By partnering with them, we’re able to bring our AI tools to hundreds of clinics that are already digitized but want to go further—unlocking the full potential of their data to drive smarter decisions, reduce waste, and ultimately help more families grow.”
